Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025
Werte in diesem Artikel
BOSTON, Jan. 8, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2025 financial results at 6:00 am ET on Thursday, February 6, 2025. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on February 6, 2025.
The call can be accessed via teleconference at: Q3 2025 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/63jte4ra
A replay of the conference call and webcast will be available for one year beginning on February 6, 2025 at 11:00 am ET using the conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: | ||
Olga Guyette, Vice President-Investor Relations & Treasury | David Trenk, Manager-Investor Relations | |
(781) 356-9763 | (203) 733-4987 | |
Media Contact: | ||
Josh Gitelson, Sr. Director-Global Communications | ||
(781) 356-9776 | ||
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-third-quarter-fiscal-year-2025-results-february-6-2025-302346400.html
SOURCE Haemonetics Corporation
Ausgewählte Hebelprodukte auf Haemonetics
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Haemonetics
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Haemonetics Corp.
Analysen zu Haemonetics Corp.
Datum | Rating | Analyst | |
---|---|---|---|
07.08.2019 | Haemonetics Outperform | Barrington Research | |
08.05.2019 | Haemonetics Outperform | Barrington Research | |
09.08.2018 | Haemonetics Outperform | Barrington Research | |
07.02.2018 | Haemonetics Outperform | Barrington Research | |
08.11.2017 | Haemonetics Outperform | Barrington Research |
Datum | Rating | Analyst | |
---|---|---|---|
07.08.2019 | Haemonetics Outperform | Barrington Research | |
08.05.2019 | Haemonetics Outperform | Barrington Research | |
09.08.2018 | Haemonetics Outperform | Barrington Research | |
07.02.2018 | Haemonetics Outperform | Barrington Research | |
08.11.2017 | Haemonetics Outperform | Barrington Research |
Datum | Rating | Analyst | |
---|---|---|---|
07.02.2017 | Haemonetics Mkt Perform | Barrington Research | |
07.11.2016 | Haemonetics Hold | The Benchmark Company | |
11.05.2016 | Haemonetics Hold | The Benchmark Company | |
05.11.2015 | Haemonetics Hold | The Benchmark Company | |
16.08.2006 | Update Haemonetics Corp.: Hold | Stanford Research |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Haemonetics Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen